Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Triple receptor activity: GLP-1, GIP, and glucagon Appetite and satiety pathway support Energy expenditure and fat metabolism research Body weight reduction in clinical trials Potential metabolic health improvements A possible future option for clients who have plateaued on existing therapies In a phase 2 trial published in The New England Journal of Medicine, adults with obesity who received Retatrutide for 48 weeks had substantial reductions in body weight, with the 12 mg group showing a mean percentage change of -24.2% compared with -2.1% for placebo
F.ZhangZ.HuD
Use reconstituted Solution immediately Caution: The injection should not be used if it contains visible particulate matter after reconstitution
Abstract Metformin is the initial medication recommended for the treatment of type 2 diabetes mellitus (T2DM)
US$ 24.18
US$ 28.18
US$ 23.84
US$ 21.82
US$ 24.75
US$ 23.82
